Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux GP, Hardwigsen J, Benkhatar Y, Derquenne F, Conti F. Saliba F, et al. Among authors: vanlemmens c. Liver Int. 2022 Nov;42(11):2513-2523. doi: 10.1111/liv.15396. Epub 2022 Sep 1. Liver Int. 2022. PMID: 35962772 Free PMC article.
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group.
Poynard T, Naveau S, Doffoel M, Boudjema K, Vanlemmens C, Mantion G, Messner M, Launois B, Samuel D, Cherqui D, Pageaux G, Bernard PH, Calmus Y, Zarski JP, Miguet JP, Chaput JC. Poynard T, et al. Among authors: vanlemmens c. J Hepatol. 1999 Jun;30(6):1130-7. doi: 10.1016/s0168-8278(99)80269-4. J Hepatol. 1999. PMID: 10406193 Clinical Trial.
Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease.
Miguet M, Monnet E, Vanlemmens C, Gache P, Messner M, Hruskovsky S, Perarnau JM, Pageaux GP, Duvoux C, Minello A, Hillon P, Bresson-Hadni S, Mantion G, Miguet JP. Miguet M, et al. Among authors: vanlemmens c. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):845-51. doi: 10.1016/s0399-8320(04)95146-9. Gastroenterol Clin Biol. 2004. PMID: 15523219 Free article.
Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.
Nevens F, Zuckerman JN, Burroughs AK, Jung MC, Bayas JM, Kallinowski B, Rivas EF, Duvoux C, Neuhaus P, Saliba F, Buti M, Zarski JP, Pons F, Vanlemmens C, Hamtiaux V, Stoffel M. Nevens F, et al. Among authors: vanlemmens c. Liver Transpl. 2006 Oct;12(10):1489-95. doi: 10.1002/lt.20836. Liver Transpl. 2006. PMID: 16964595 Free article. Clinical Trial.
Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
Pageaux GP, Rostaing L, Calmus Y, Duvoux C, Vanlemmens C, Hardgwissen J, Bernard PH, Barbotte E, Vercambre L, Bismuth M, Puche P, Navarro F, Larrey D. Pageaux GP, et al. Among authors: vanlemmens c. Liver Transpl. 2006 Dec;12(12):1755-60. doi: 10.1002/lt.20903. Liver Transpl. 2006. PMID: 17133564 Free article. Clinical Trial.
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
Dharancy S, Boitard J, Decaens T, Sergent G, Boleslawski E, Duvoux C, Vanlemmens C, Meyer C, Gugenheim J, Durand F, Boillot O, Declerck N, Louvet A, Canva V, Romano O, Ernst O, Mathurin P, Pruvot FR. Dharancy S, et al. Among authors: vanlemmens c. Liver Transpl. 2007 May;13(5):665-71. doi: 10.1002/lt.21109. Liver Transpl. 2007. PMID: 17427172 Free article. Clinical Trial.
84 results